Mission
ADVANCING CLINICAL PHARMACOLOGY, TRANSLATIONAL MEDICINE AND THERAPEUTICS FOR THE BENEFIT OF PATIENTS AND SOCIETY.
Public Charity
AMERICAN SOCIETY FOR CLINICAL PHARMACOLOGY & THERAPEUTICS
Based in ALEXANDRIA, VA, AMERICAN SOCIETY FOR CLINICAL PHARMACOLOGY & THERAPEUTICS operates as a Public Charity. The organization reported $4.3M in revenue, $4.2M in expenses, $7.7M in total assets for fiscal year 2024. Imperigo tracks 2 reported grant relationships connected to this organization totaling approximately $15K.
EIN: 231682043
ALEXANDRIA, VA
Health Care
NTEE: E
Latest filing: 2024
Total Revenue$4.3M
Total Expenses$4.2M
Total Assets$7.7M
Grant Records2
Funding Total$15K
Filing Years2019–2024
Where $100 goes at American Society for Clinical Pharmacology & Therapeutics
How American Society for Clinical Pharmacology & Therapeutics divides every $100 it spends, from its own Form 990 filings, averaged across 7 years.
$89
Programs
the work itself
$11
Management
running the organization
$0
Fundraising
none reported
No fundraising costs are reported. That often means fundraising runs through a separate affiliated organization that files its own return.
Inside the $89 for programs
$43
Annual meeting
$30
Journal
$16
Member services
Source: Form 990 filings with the IRS, latest fiscal year 2024. Shares are from the organization's reported expenses. Data by Imperigo; not affiliated with the IRS.
Sample Grants Received
HEALTH
$10,000
For grant recipient's exempt purposes
$5,250
Showing up to 5 of 2 total records — full history available with membership.
Officers & Directors
CHIEF EXECUTIVE OFFICER
Abigail Gorman
MANAGING EDITOR
Alethea Gerding
DIRECTOR
Antoinette Ajavon-Hartmann Phd
DIRECTOR
Anu Ramamoorthy Phd
DIRECTOR (UNTIL 4/2024)
Daniele Ouellet Phd
CHIEF OPERATING OFFICER
Elise Laffman-Johnson
Officer compensation and complete director data available with membership.
Top Grant Purposes
Financial Trends
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2024 | $4.3M | $4.2M | $7.7M |
| 2023 | $3.7M | $4.1M | $6.5M |
| 2022 | $3.6M | $3.3M | $6.5M |
| 2020 | $2.1M | $2.7M | $5.3M |
| 2019 | $4.0M | $3.7M | $5.8M |
Between 2019 and 2024, reported annual revenue grew from $4.0M to $4.3M (+7%), with total assets most recently reported at $7.7M.
Interactive year-over-year charts and full filing details available with membership.